Stock listing

Defence Therapeutics Inc Class A

Selected listing: A3CN14 · LSX · EUR · DE

Defence Therapeutics Inc Class A (LS Exchange: A3CN14), Health Technology. Latest release Oct 1, 2026: Defence Therapeutics to Take the Stage at World ADC San…

A3CN14:LSXEURDEUpdated October 2, 2026

Ticker: LS Exchange: A3CN14
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LS Exchange
Currency: EUR

About Defence Therapeutics Inc Class A

The company focuses on developing innovative therapeutic solutions. Investors can find more information about its operations and performance on its dedicated public company page.

Latest news from Defence Therapeutics Inc Class A

Defence Therapeutics to Take the Stage at World ADC San Diego to Discuss the Next Frontier in Antibody-Drug Conjugates

October 1, 2026

Defence Therapeutics Appoints Finance Executive Sherry Aulin to Its Board of Directors

September 29, 2026

Defence Therapeutics Provides Corporate Update as Company Executes on Strategic Priorities

September 28, 2026

Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders

September 8, 2026

Defence Therapeutics Provides Updates on Sharing Agreement

September 4, 2026

All Defence Therapeutics Inc Class A news →

Research Defence Therapeutics Inc Class A

Defence Therapeutics Inc Class A company profile

View the public company page for Defence Therapeutics Inc Class A on 6ix.

Defence Therapeutics Inc Class A news

Read company news and market updates connected to Defence Therapeutics Inc Class A.

Defence Therapeutics Inc Class A investor events

Find investor webinars, events, and replay context for Defence Therapeutics Inc Class A.